fluphenazine has been researched along with scopolamine hydrobromide in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (63.64) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Crow, TJ; Deakin, JF; Longden, A | 1 |
Zetler, G | 1 |
Nymark, M | 1 |
Burchinsky, SG | 1 |
Ritchie, JA; Truelove, SC | 1 |
Furukawa, T; Yamada, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
2 review(s) available for fluphenazine and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neurotransmitter receptors in the central nervous system and aging: pharmacological aspect (review).
Topics: Adenylyl Cyclases; Aging; Animals; Brain; Desipramine; Dopamine; Dopamine Antagonists; Female; Fluphenazine; Haloperidol; Humans; Male; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Cholinergic; Receptors, Dopamine; Receptors, GABA-A; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Serotonin; Reserpine; Scopolamine; Spiperone; Tetrahydronaphthalenes; Tissue Distribution; Tritium | 1984 |
1 trial(s) available for fluphenazine and scopolamine hydrobromide
Article | Year |
---|---|
Comparison of various treatments for irritable bowel syndrome.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Colonic Diseases, Functional; Dietary Fiber; Drug Combinations; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lorazepam; Male; Middle Aged; Nortriptyline; Phenethylamines; Random Allocation; Scopolamine | 1980 |
8 other study(ies) available for fluphenazine and scopolamine hydrobromide
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Chlorpromazine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Homovanillic Acid; Humans; Male; Psychotic Disorders; Rats; Receptors, Dopamine; Scopolamine; Tegmentum Mesencephali; Thioridazine; Tranquilizing Agents | 1977 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Apomorphine provoked stereotype in the dog.
Topics: Amitriptyline; Animals; Anisoles; Apomorphine; Atropine; Behavior, Animal; Benzamides; Benztropine; Diazepam; Diphenhydramine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Ethylamines; Female; Fluphenazine; Haloperidol; Humans; Male; Methyltyrosines; Motor Activity; Phenoxybenzamine; Piperazines; Receptors, Drug; Scopolamine; Stereotyped Behavior; Xanthenes | 1972 |
Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Antagonists; Fluphenazine; Humans; Male; Parasympathetic Nervous System; Physostigmine; Pilocarpine; Rats; Reflex; Reserpine; Scopolamine; Stereotyped Behavior | 1980 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |